Literature DB >> 8125515

Role of cytokines in tuberculosis.

I E Flesch1, S H Kaufmann.   

Abstract

Mycobacterium tuberculosis and Mycobacterium bovis are facultative intracellular pathogens which preferentially utilize the macrophage as their host cell. Acquired resistance against mycobacteria depends on T cells which activate antimicrobial macrophage functions via the release of cytokines. The data summarized below suggest an important role for interferon-gamma (IFN-gamma) as well as the B cell-stimulatory factors interleukin-4 (IL-4) and IL-6 in the induction of tuberculostatic macrophage functions. Growth inhibition of mycobacteria by cytokine-stimulated macrophages is mediated by reactive nitrogen intermediates (RNI) derived from L-arginine. Tumor necrosis factor-alpha (TNF-alpha) and IL-10 act as autocrine regulators in the induction of the enzyme NO-synthase. Both cytokines are produced by macrophages stimulated with IFN-gamma and infected with M. bovis. While TNF-alpha mediates activation of the NO-synthase and production of RNI, IL-10 suppresses this enzyme activity. The outcome of mycobacterial infection is probably regulated by a complex network between stimulatory and inhibitory cytokines.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8125515     DOI: 10.1016/S0171-2985(11)80364-5

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  27 in total

1.  Dynamic changes in circulating and antigen-responsive T-cell subpopulations post-Mycobacterium bovis infection in cattle.

Authors:  J M Pollock; D A Pollock; D G Campbell; R M Girvin; A D Crockard; S D Neill; D P Mackie
Journal:  Immunology       Date:  1996-02       Impact factor: 7.397

2.  NOD2 controls the nature of the inflammatory response and subsequent fate of Mycobacterium tuberculosis and M. bovis BCG in human macrophages.

Authors:  Michelle N Brooks; Murugesan V S Rajaram; Abul K Azad; Amal O Amer; Martin A Valdivia-Arenas; Jong-Hwan Park; Gabriel Núñez; Larry S Schlesinger
Journal:  Cell Microbiol       Date:  2010-11-24       Impact factor: 3.715

Review 3.  Immunopathology of tuberculosis: roles of macrophages and monocytes.

Authors:  M J Fenton; M W Vermeulen
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

4.  Apoptosis of Th1-like cells in experimental tuberculosis (TB).

Authors:  G Das; H Vohra; B Saha; J N Agrewala; G C Mishra
Journal:  Clin Exp Immunol       Date:  1999-02       Impact factor: 4.330

5.  Environmental strains of Mycobacterium avium interfere with immune responses associated with Mycobacterium bovis BCG vaccination.

Authors:  Sarah L Young; Lynn Slobbe; Rachel Wilson; Bryce M Buddle; Geofferey W de Lisle; Glenn S Buchan
Journal:  Infect Immun       Date:  2007-03-19       Impact factor: 3.441

6.  Induction of inducible nitric oxide synthase-NO* by lipoarabinomannan of Mycobacterium tuberculosis is mediated by MEK1-ERK, MKK7-JNK, and NF-kappaB signaling pathways.

Authors:  E D Chan; K R Morris; J T Belisle; P Hill; L K Remigio; P J Brennan; D W Riches
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

7.  Mycobacterium bovis BCG-induced granuloma formation depends on gamma interferon and CD40 ligand but does not require CD28.

Authors:  L H Hogan; W Markofski; A Bock; B Barger; J D Morrissey; M Sandor
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

Review 8.  [Immunology of tuberculosis: impact on the development of novel vaccines].

Authors:  T Ulrichs; S H E Kaufmann
Journal:  Internist (Berl)       Date:  2003-11       Impact factor: 0.743

9.  Induction of nitric oxide release from the human alveolar epithelial cell line A549: an in vitro correlate of innate immune response to Mycobacterium tuberculosis.

Authors:  Sugata Roy; Sadhna Sharma; Monika Sharma; Ramesh Aggarwal; Mridula Bose
Journal:  Immunology       Date:  2004-07       Impact factor: 7.397

10.  Relapsing fever borreliosis in interleukin-10-deficient mice.

Authors:  Diana Londoño; Adriana Marques; Ronald L Hornung; Diego Cadavid
Journal:  Infect Immun       Date:  2008-09-15       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.